Coronavirus Ten of them are in Stage Three
THe’s the whole world watching with deep interest as scientists work to find one Vaccine stop pandemic coronavirus.
They are trying to produce vaccines in record time, with 44.5 million active cases has been recorded worldwide and with 1.1 million deaths. Here’s a look at the top vaccine programs and how they work.
As of October 19, the date with the most recent data, There are 154 projects in the pre-clinical phase and 44 others have passed that stage and are in the clinical phase.. Then there are 10 in Phase Three, pre-approval and commercialization stages. Here is a look at the top ones.
-Very Jenner of Oxford University (UK). This experimental vaccine is not only for the complete immune response in young people but also in the more vulnerable elderly.
-Janssen / Johnson & Johnson (USA). In this case, they announced a discontinuation of the drug administration to investigate a participant’s “unexplained illness”.
-Modern (USA). Know in November if their COVID-19 vaccine, named mRNA-1273, is effective. If so, an urgent approval request will be made in December.
-Novavax (USA). They found a positive immune response, albeit with moderate side effects in the majority of participants.
-Sinovac (China). According to estimates by the pharmaceutical company, the vaccine could be widely released as early as next year. They believe they can produce 300 million doses per year.
-Sinopharm / Wuhan Institute of Biological Products (China). These are two independent projects, with Sinopharm behind. Both are in the final stages of clinical trials.
-BioNTech / Fosun Pharma / Pfizer (Germany / USA). The goal is to produce up to 100 million doses of the vaccine remaining this year and potentially more than 1,200 doses by 2021.
-Gamaleya Research Institute (Russia). Preliminary results from clinical trials showed no adverse events and they thought that antibodies could be produced.
-CanSino Biological Inc. / Beijing Institute of Biotechnology (China). After the positive signs of this project, the Chinese intellectual property office approved the first patent for this candidate. That means it can be mass produced in a short time.
The RUTI vaccine against COVID-19, being developed by researchers at the German Hospital Trias i Pujol and produced by Archivel Farma, was the first Spanish vaccine to be approved for international clinical trials. , will take place in Argentina.